Compare NCV & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NCV | NRC |
|---|---|---|
| Founded | 2003 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 358.8M | 390.8M |
| IPO Year | N/A | 1997 |
| Metric | NCV | NRC |
|---|---|---|
| Price | $16.15 | $17.84 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 93.3K | 68.9K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | ★ 12.48% | 3.76% |
| EPS Growth | N/A | ★ 4707.69 |
| EPS | N/A | ★ 50.00 |
| Revenue | N/A | ★ $119,686,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.34 |
| Revenue Growth | N/A | ★ 1.81 |
| 52 Week Low | $12.22 | $9.76 |
| 52 Week High | $16.70 | $22.79 |
| Indicator | NCV | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 60.56 | 61.27 |
| Support Level | $14.91 | $17.85 |
| Resistance Level | $16.28 | $18.18 |
| Average True Range (ATR) | 0.32 | 0.73 |
| MACD | 0.15 | -0.04 |
| Stochastic Oscillator | 78.22 | 95.10 |
Virtus Convertible & Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and high current income. It intends to achieve the objective by investing in a portfolio of domestic convertible securities and non-convertible income-producing securities. Its portfolio of investments includes Software, the Internet, the Commercial Services sector in the form of Convertible Bonds and Notes, and Media, Oil, Gas & Consumable Fuels, and Entertainment sector in the form of Corporate Bonds and Notes.
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The company operates in the United States and Canada, of which key revenue is derived from the United States.